Wilco Kwanten
@kvvanten
Followers
67
Following
2K
Media
32
Statuses
145
Enthousiast in alles wat ik doe / interesse in lever en pancreas / Antwerpen #AntwerpHepatology
Joined May 2019
Onderzoekers luiden alarmbel over georganiseerde fraude in de wetenschap: artikels en citaties te koop
demorgen.be
Fraude met wetenschappelijke artikels is van alle tijden, maar uit betrouwbaar onderzoek blijkt dat de oplichting op dit moment grootschaliger en beter georganiseerd is dan gedacht. ‘Meer en meer...
0
0
0
RT @EuropeLiver: Join the “Mind the Liver” study — because your story can help to change health care. Are you living with MASLD (formerly N….
0
7
0
In the (early) pathophysiology of MASLD the LSEC and microvascular alterations are key. Lanifibranor improves LSEC capillarisation and dysfunction! .#AntwerpHepatology #AntwerpHypothesis @RautouE @FrancqueSven
0
1
2
📢📢 Analysis of 249 patients with MASLD and of 2 rat models:.⚠️Liver endothelial cell (LSEC) capillarisation appears before MASH onset .❌LSEC capillarisation progresses with liver fibrosis and inflammation .✅Lanifibranor improves LSEC function.
0
0
1
RT @DinaTiniakos: Who better than Christine Sempoux 👌to describe the 🔬pathology of vascular liver disease? Great digestive🔬🩺 session organi….
0
1
0
🩺Sven Francque meets 🔬#BelgianGastroenterologyWeek 🇧🇪. Liver biopsy has reduced but significant role in #liver disease diagnosis depending on aetiology. Still ⭐️for #MASH! @EASLnews @ESP_Pathology @my_ueg @ukingreece @LiverPath_HPHS
0
0
1
RT @DinaTiniakos: 🩺Sven Francque meets 🔬#BelgianGastroenterologyWeek 🇧🇪. Liver biopsy has reduced but significant role in #liver disease di….
0
3
0
Joining a great event around organ transplantation including a discussion on donation after euthanasia. #foodforthought #donation #transplantation #UZA #AntwerpHepatology
0
0
0
RT @ERN_RARE_LIVER: 📢 Join the ERN RARE-LIVER Webinar: Contraception & Fertility in Rare Liver Diseases. 🗓️ 17 Dec 2024, 5 PM (CET).💡 Topic….
0
2
0
RT @JHepatology: 📌In our November issue. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortali….
0
30
0
RT @EuropeLiver: 🎗️✨ As #LiverCancerAwarenessMonth and #EuropeanLiverScreeningWeek draw to a close, we are profoundly grateful for the effo….
0
9
0
RT @TheLancet: Steatotic liver disease affects ~30% of the global population. A Review by @IsraelsenMads, @FrancqueSven, Emmanual Tsochatz….
0
84
0
RT @juanpabloarab: Great study and great authors. very insightful discussion. If you missed it, here is your opportunity to watch it! #Li….
0
1
0
RT @ReibergerThomas: @EASLedu #JournalClub.➡️ on demand 📺. @juanpabloarab challenged our study: .@kvvanten @BenediktHofer @FrancqueSven .on….
0
2
0
Today I had the honour to present our paper at the EASL journal club! #EASLJC #Proud #AntwerpHepatology @ReibergerThomas @FrancqueSven @BenediktHofer @EASLedu @BavenoCoop
0
2
12
RT @ReibergerThomas: 🚨#LiverTwitter. 🎙️@EASLnews @EASLedu Discussion.study by @kvvanten & @BenediktHofer @JHepatology . 🥼#PortalHypertensio….
0
17
0
RT @LancetGastroHep: Linked Comment - Sven M Francque & Luisa Vonghia - Expanding the armamentarium for metabolic dysfunction-associated st….
thelancet.com
The treatment of metabolic dysfunction-associated steatohepatitis (MASH) has proven challenging, with many compounds failing during development for various reasons. However, with the recent acceler...
0
4
0